Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Laruelle

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|August 5, 2005
A positron emission tomography radioligand for the in vivo labeling of metabotropic glutamate 1 receptor: (3-ethyl-2-[11C]methyl-6-quinolinyl)(cis- 4-methoxycyclohexyl)methanoneYiyun Huang, Raj Narendran, François Bischoff, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 12, 2003
Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB)Qian Li, Li Ma, Robert B Innis, et al.
Neuroimage|February 24, 2009
Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PETAna M Catafau, Marina Suarez, Santiago Bullich, et al.
Nuclear Medicine and Biology|March 8, 2003
Evaluation of [3H]LY341495 for labeling group II metabotropic glutamate receptors in vivoRikki N Waterhouse, Mark E Schmidt, Abida Sultana, et al.
Nuclear Medicine and Biology|October 17, 2002
Synthesis and pharmacological characterization of a new PET ligand for the serotonin transporter: [11C]5-bromo-2-[2-(dimethylaminomethylphenylsulfanyl)]phenylamine ([11C]DAPA)Yiyun Huang, Dah-Ren Hwang, Zhihong Zhu, et al.
Synapse (New York, N.Y.)|August 29, 2012
Synthesis and characterization of two PET radioligands for the metabotropic glutamate 1 (mGlu1) receptorYiyun Huang, Rajesh Narendran, Francois Bischoff, et al.
Depression and Anxiety|January 26, 2007
Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findingsFranklin R Schneier, Diana Martinez, Anissa Abi-Dargham, et al.
Synapse (New York, N.Y.)|May 4, 2011
Characterization of in vivo pharmacological properties and sensitivity to endogenous serotonin of [11C] P943: a positron emission tomography study in Papio anubisKhanum Ridler, Christophe Plisson, Eugenii A Rabiner, et al.
Synapse (New York, N.Y.)|September 5, 2006
Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivoRajesh Narendran, Mark Slifstein, Olivier Guillin, et al.
Schizophrenia Research|February 21, 2002
Cognitive and brain function in schizotypal personality disorderLarry J Siever, Harold W Koenigsberg, Philip Harvey, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|August 5, 2005
A positron emission tomography radioligand for the in vivo labeling of metabotropic glutamate 1 receptor: (3-ethyl-2-[11C]methyl-6-quinolinyl)(cis- 4-methoxycyclohexyl)methanoneYiyun Huang, Raj Narendran, François Bischoff, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 12, 2003
Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB)Qian Li, Li Ma, Robert B Innis, et al.
Neuroimage|February 24, 2009
Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PETAna M Catafau, Marina Suarez, Santiago Bullich, et al.
Nuclear Medicine and Biology|March 8, 2003
Evaluation of [3H]LY341495 for labeling group II metabotropic glutamate receptors in vivoRikki N Waterhouse, Mark E Schmidt, Abida Sultana, et al.
Nuclear Medicine and Biology|October 17, 2002
Synthesis and pharmacological characterization of a new PET ligand for the serotonin transporter: [11C]5-bromo-2-[2-(dimethylaminomethylphenylsulfanyl)]phenylamine ([11C]DAPA)Yiyun Huang, Dah-Ren Hwang, Zhihong Zhu, et al.
Synapse (New York, N.Y.)|August 29, 2012
Synthesis and characterization of two PET radioligands for the metabotropic glutamate 1 (mGlu1) receptorYiyun Huang, Rajesh Narendran, Francois Bischoff, et al.
Depression and Anxiety|January 26, 2007
Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findingsFranklin R Schneier, Diana Martinez, Anissa Abi-Dargham, et al.
Synapse (New York, N.Y.)|May 4, 2011
Characterization of in vivo pharmacological properties and sensitivity to endogenous serotonin of [11C] P943: a positron emission tomography study in Papio anubisKhanum Ridler, Christophe Plisson, Eugenii A Rabiner, et al.
Synapse (New York, N.Y.)|September 5, 2006
Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivoRajesh Narendran, Mark Slifstein, Olivier Guillin, et al.
Schizophrenia Research|February 21, 2002
Cognitive and brain function in schizotypal personality disorderLarry J Siever, Harold W Koenigsberg, Philip Harvey, et al.
Pageof 11